ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0191

Increased Frequency of Lower Limb Arterial Obstruction in Rheumatoid Arthritis

Ahmed Oglah1, Ali Hussein2, Jose Felix Restrepo3, Carlos Lorenzo3, Agustin Escalante3 and Inmaculada Del Rincon3, 1University of Texas Health Science Center at San Antonio/ Internal Medicine Residency program, San Antonio, TX, 2University of Texas Health Science Center at San Antonio/ Department of Internal Medicine/ Rheumatology, San Antonio, TX, 3University of Texas Health Science Center at San Antonio/ Department of Medicine/ Rheumatology, San Antonio, TX

Meeting: ACR Convergence 2020

Keywords: Atherosclerosis, Peripheral Vascular Disease, rheumatoid arthritis, risk factors, Subclinical Cardiovascular Disease

  • Tweet
  • Email
  • Print
Session Information

Date: Friday, November 6, 2020

Title: RA – Diagnosis, Manifestations, & Outcomes Poster I: Multimorbidity

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Despite a high frequency of cardiovascular disease in rheumatoid arthritis (RA), peripheral arterial disease in RA has received little attention. The objective of the present analysis was to examine the frequency of impaired lower limb arterial function in members of an RA cohort, compared to a control group without RA.

Methods: Patients meeting diagnostic criteria for RA were recruited consecutively from private and public rheumatology practices, from 1996 through 2011. For comparison, we studied participants in the Insulin Resistance and Atherosclerosis Study (IRAS), who were recruited from four clinical centers based on blood glucose tolerance status indicating normal glucose tolerance, impaired glucose tolerance, or diabetes mellitus. The clinical centers were in Los Angeles, Oakland, San Antonio and the San Luis valley in Colorado. The ABI was measured using a blood pressure cuff and a doppler ultrasound probe to measure the systolic blood pressure (SBP) in all four extremities. The ABI was calculated for each ankle provided as the ratio of highest SBP in the ankle to the highest SBP in the upper extremities. The ABI was considered obstructed if ≤0.9, normal if >0.9 but ≤1.3, and incompressible if >1.3. Logistic regression was used to compare the frequency of obstruction or incompressibility between RA and controls, adjusting for age, sex, smoking, diabetes mellitus and hypertension.

Results: We recruited 1328 RA patients, of whom 1182 had an ABI measurement. Their mean age was 58 (range 19-91), and 887 (75%) were women. They were compared to 1624 IRAS study participants, whose mean age was 55 (range 39-69), and 905 were women (55%). An obstructed ABI was present in 113 of the RA patients (9.56%), and in 53 of the IRAS participants (3.26%), odds ratio (OR) 3.09, CI 95% 2.18, 4.41, p< 0.0001. Adjusting for age, sex, smoking, diabetes and hypertension, the frequency of obstruction remained higher in the RA group with an OR of 3.74, CI 95% 2.5, 5.59, P < 0.0001. (Figure) An incompressible ABI was present in 183 of the RA patients (15.48%), and in 286 of the IRAS participants (17.6%), OR 0.92, CI 95% 0.75, 1.14. P 0.47. Multivariable adjustment did not alter the odds of incompressibility between the two groups.

Conclusion: Our findings suggesting an increased frequency of peripheral arterial obstruction in RA patients broadens the scope of cardiovascular morbidity in RA. The clinical significance of the increased frequency of peripheral arterial obstruction in RA deserves further study.

Figure: Unadjusted and adjusted frequency of obstructed ankle brachial index in rheumatoid arthritis and controls. Error bars represent 95% confidence intervals.


Disclosure: A. Oglah, None; A. Hussein, None; J. Restrepo, None; C. Lorenzo, None; A. Escalante, None; I. Del Rincon, None.

To cite this abstract in AMA style:

Oglah A, Hussein A, Restrepo J, Lorenzo C, Escalante A, Del Rincon I. Increased Frequency of Lower Limb Arterial Obstruction in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/increased-frequency-of-lower-limb-arterial-obstruction-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-frequency-of-lower-limb-arterial-obstruction-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology